Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,510 | -14,635 | -10,038 | -6,060 | -5,789 |
| Depreciation Amortization | 1,562 | 5,996 | 1,284 | 1,428 | 1,892 |
| Accounts payable and accrued liabilities | 950 | -119 | -125 | -448 | -21 |
| Other Working Capital | 2,470 | 1,928 | 1,342 | 639 | 964 |
| Other Operating Activity | 2,821 | 1,824 | 3,294 | 1,897 | 658 |
| Operating Cash Flow | $-3,707 | $-5,007 | $-4,243 | $-2,544 | $-2,297 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 33 | -218 | 148 | -91 | 196 |
| Debt Issued | 0 | 1,969 | 4,000 | 3,250 | 2,068 |
| Common Stock Issued | 3,632 | 3,434 | 0 | N/A | 49 |
| Other Financing Activity | 0 | -107 | -95 | -125 | 0 |
| Financing Cash Flow | $3,665 | $5,078 | $4,053 | $3,034 | $2,312 |
| Beginning Cash Position | 389 | 317 | 507 | 17 | 1 |
| End Cash Position | 346 | 389 | 317 | 507 | 17 |
| Net Cash Flow | $-43 | $72 | $-190 | $490 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,707 | -5,007 | -4,243 | -2,544 | -2,297 |
| Free Cash Flow | -3,707 | -5,007 | -4,243 | -2,544 | -2,297 |